David Voduc

11.8k total citations · 4 hit papers
20 papers, 8.0k citations indexed

About

David Voduc is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, David Voduc has authored 20 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in David Voduc's work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (9 papers) and Breast Lesions and Carcinomas (4 papers). David Voduc is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (9 papers) and Breast Lesions and Carcinomas (4 papers). David Voduc collaborates with scholars based in Canada, United States and Spain. David Voduc's co-authors include Torsten O. Nielsen, Maggie C.U. Cheang, Samuel Leung, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis, Sherri R. Davies, Joel S. Parker, Stephen Chia and Karen A. Gelmon and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Surgery.

In The Last Decade

David Voduc

20 papers receiving 7.9k citations

Hit Papers

Supervised Risk Predictor... 2008 2026 2014 2020 2009 2009 2010 2008 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
    2009 3.1k citations Joel S. Parker, Michael E. Mullins et al. Journal of Clinical Oncology profile →
  2. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
    2009 1.6k citations Maggie C.U. Cheang, Stephen Chia et al. JNCI Journal of the National Cancer Institute profile →
  3. Metastatic Behavior of Breast Cancer Subtypes
    2010 1.6k citations Hagen F. Kennecke, Rinat Yerushalmi et al. Journal of Clinical Oncology profile →
  4. Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
    2008 945 citations Maggie C.U. Cheang, David Voduc et al. Clinical Cancer Research profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Voduc 4.5k 4.5k 3.1k 1.6k 1.0k 20 8.0k
Sherri R. Davies 3.3k 0.7× 4.0k 0.9× 3.0k 1.0× 1.0k 0.7× 887 0.9× 36 6.9k
Chungyeul Kim 3.7k 0.8× 4.8k 1.1× 2.6k 0.8× 1.2k 0.8× 1.3k 1.3× 56 7.4k
Janine Salter 5.1k 1.1× 4.8k 1.1× 2.9k 0.9× 1.3k 0.8× 1.2k 1.2× 86 8.8k
Daniel J. Booser 5.2k 1.1× 3.5k 0.8× 2.3k 0.8× 1.2k 0.8× 910 0.9× 105 8.1k
Minetta C. Liu 3.4k 0.8× 2.9k 0.6× 1.9k 0.6× 1.6k 1.0× 587 0.6× 204 6.0k
Sabine C. Linn 4.7k 1.0× 3.4k 0.8× 3.2k 1.1× 2.4k 1.5× 1.1k 1.0× 231 9.1k
Anne‐Lise Børresen‐Dale 6.0k 1.3× 6.1k 1.4× 6.3k 2.0× 1.7k 1.1× 1.4k 1.4× 26 12.4k
Rinat Yerushalmi 4.4k 1.0× 2.3k 0.5× 2.2k 0.7× 1.8k 1.1× 694 0.7× 119 6.7k
Kenna Shaw 2.3k 0.5× 3.2k 0.7× 4.7k 1.5× 1.6k 1.0× 988 1.0× 83 7.9k
D. Craig Allred 4.5k 1.0× 3.4k 0.8× 2.8k 0.9× 931 0.6× 1.0k 1.0× 54 7.5k

Countries citing papers authored by David Voduc

Since Specialization
Citations

This map shows the geographic impact of David Voduc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Voduc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Voduc more than expected).

Fields of papers citing papers by David Voduc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Voduc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Voduc. The network helps show where David Voduc may publish in the future.

Co-authorship network of co-authors of David Voduc

This figure shows the co-authorship network connecting the top 25 collaborators of David Voduc. A scholar is included among the top collaborators of David Voduc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Voduc. David Voduc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Joel S., Michael E. Mullins, Maggie C.U. Cheang, et al.. (2023). Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. Journal of Clinical Oncology. 41(26). 4192–4199. 23 indexed citations
2.
Speers, Caroline, et al.. (2017). Neoadjuvant Systemic Therapy in Breast Cancer: Use and Trends in Radiotherapy Practice. Current Oncology. 24(5). 310–317. 3 indexed citations
3.
4.
Liu, Fei‐Fei, Wei Shi, Susan J. Done, et al.. (2015). Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy. Journal of Clinical Oncology. 33(18). 2035–2040. 96 indexed citations
5.
Cheang, Maggie C.U., Miguel Martín, Torsten O. Nielsen, et al.. (2012). Quantitative hormone receptors, triple-negative breast cancer (TNBC), and molecular subtypes: A collaborative effort of the BIG-NCI NABCG.. Journal of Clinical Oncology. 30(15_suppl). 1008–1008. 10 indexed citations
6.
Chiu, Connie G., Hamid Masoudi, Samuel Leung, et al.. (2010). HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival. Annals of Surgery. 251(6). 1107–1116. 45 indexed citations
7.
Kennecke, Hagen F., Rinat Yerushalmi, Ryan Woods, et al.. (2010). Metastatic Behavior of Breast Cancer Subtypes. Journal of Clinical Oncology. 28(20). 3271–3277. 1633 indexed citations breakdown →
8.
Parker, Joel S., Michael E. Mullins, Maggie C.U. Cheang, et al.. (2009). Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. Journal of Clinical Oncology. 27(8). 1160–1167. 3093 indexed citations breakdown →
9.
Cheang, Maggie C.U., Stephen Chia, David Voduc, et al.. (2009). Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer. JNCI Journal of the National Cancer Institute. 101(10). 736–750. 1641 indexed citations breakdown →
10.
Kennecke, Hagen F., David Voduc, Suet Yi Leung, et al.. (2009). α-basic-crystallin expression in basal-like breast cancer and its association with brain metastasis. Journal of Clinical Oncology. 27(15_suppl). 1025–1025. 1 indexed citations
11.
Nielsen, Torsten O., Maggie C.U. Cheang, Stephen Chia, et al.. (2009). Response: Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer. JNCI Journal of the National Cancer Institute. 101(24). 1730–1731. 31 indexed citations
12.
Voduc, David & Torsten O. Nielsen. (2008). Basal and Triple-Negative Breast Cancers: Impact on Clinical Decision-Making and Novel Therapeutic Options. Clinical Breast Cancer. 8. S171–S178. 12 indexed citations
13.
Voduc, David, et al.. (2008). Tissue Microarrays in Clinical Oncology. Seminars in Radiation Oncology. 18(2). 89–97. 95 indexed citations
14.
Voduc, David, Torsten O. Nielsen, Maggie C.U. Cheang, & William D. Foulkes. (2008). The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype. Human Pathology. 39(10). 1431–1437. 36 indexed citations
15.
Cheang, Maggie C.U., David Voduc, Chris Bajdik, et al.. (2008). Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype. Clinical Cancer Research. 14(5). 1368–1376. 945 indexed citations breakdown →
16.
Voduc, David, Maggie C.U. Cheang, & Torsten O. Nielsen. (2008). GATA-3 Expression in Breast Cancer Has a Strong Association with Estrogen Receptor but Lacks Independent Prognostic Value. Cancer Epidemiology Biomarkers & Prevention. 17(2). 365–373. 119 indexed citations
17.
Rajput, Ashish, Dmitry Turbin, Maggie C.U. Cheang, et al.. (2007). Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases. Breast Cancer Research and Treatment. 107(2). 249–257. 158 indexed citations
18.
Tyldesley, Scott, et al.. (2006). Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002. Urology. 67(3). 594–598. 14 indexed citations
19.
Fyles, Anthony, David Voduc, A.M. Nisar Syed, et al.. (2002). The Effect of Smoking on Tumour Oxygenation and Treatment Outcome in Cervical Cancer. Clinical Oncology. 14(6). 442–446. 11 indexed citations
20.
Voduc, David, A.M. Nisar Syed, Michael Milosevic, Melania Pintilie, & Anthony Fyles. (2001). The effect of smoking on tumor oxygenation and treatment outcome in cervical cancer. International Journal of Radiation Oncology*Biology*Physics. 51(3). 326–327. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherri R. Davies Breakdown of academic impact, for papers by Chungyeul Kim Breakdown of academic impact, for papers by Janine Salter Breakdown of academic impact, for papers by Daniel J. Booser Breakdown of academic impact, for papers by Minetta C. Liu Breakdown of academic impact, for papers by Sabine C. Linn Breakdown of academic impact, for papers by Anne‐Lise Børresen‐Dale Breakdown of academic impact, for papers by Rinat Yerushalmi Breakdown of academic impact, for papers by Kenna Shaw Breakdown of academic impact, for papers by D. Craig Allred
Rankless by CCL
2026